A
Andrew Wang
Researcher at Duke University
Publications - 199
Citations - 12259
Andrew Wang is an academic researcher from Duke University. The author has contributed to research in topics: Infective endocarditis & Endocarditis. The author has an hindex of 48, co-authored 175 publications receiving 10408 citations. Previous affiliations of Andrew Wang include Durham University & University of California.
Papers
More filters
Journal ArticleDOI
Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study
David R. Murdoch,G. Ralph Corey,Bruno Hoen,José M. Miró,Vance G. Fowler,Arnold S. Bayer,Adolf W. Karchmer,Lars Olaison,Paul A. Pappas,Philippe Moreillon,Stephen T. Chambers,Vivian H. Chu,Vicenç Falcó,David Holland,Philip Jones,John L Klein,Nigel Raymond,Kerry Read,Marie Francoise Tripodi,Riccardo Utili,Andrew Wang,Christopher W. Woods,Christopher H. Cabell +22 more
TL;DR: In the early 21st century, IE is more often an acute disease, characterized by a high rate of S aureus infection, and Mortality remains relatively high.
Journal ArticleDOI
Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation 5-Year Results of EVEREST II
Ted Feldman,Saibal Kar,Sammy Elmariah,Steven C. Smart,Alfredo Trento,Robert J. Siegel,Patricia Apruzzese,Peter S. Fail,Michael Rinaldi,Richard W. Smalling,James B. Hermiller,David Heimansohn,William A. Gray,Paul A. Grayburn,Michael J. Mack,D. Scott Lim,Gorav Ailawadi,Howard C. Herrmann,Michael A. Acker,Frank E. Silvestry,Elyse Foster,Andrew Wang,Donald D. Glower,Laura Mauri,Everest Investigators +24 more
TL;DR: Patients treated with percutaneous repair more commonly required surgery for residual MR during the first year after treatment, but between 1- and 5-year follow-up, comparably low rates of surgery for MV dysfunction with either per cutaneous or surgical therapy endorse the durability of MR reduction with both repair techniques.
Journal ArticleDOI
Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
Andrew Wang,Eugene Athan,Paul A. Pappas,Vance G. Fowler,Lars Olaison,Carlos Paré,Benito Almirante,Patricia Muñoz,Marco Rizzi,Christopher Naber,Mateja Logar,Pierre Tattevin,Diana Iarussi,Christine Selton-Suty,Sandra Braun Jones,José H. Casabé,Arthur J. Morris,G. Ralph Corey,Christopher H. Cabell +18 more
TL;DR: Staphylococcus aureus is now the leading cause of Prosthetic valve endocarditis, and health care-associated infection significantly influences the clinical characteristics and outcome of PVE.
Journal ArticleDOI
Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis
Penelope C. Georges,Jia Ji Hui,Zoltan Gombos,Margaret E. McCormick,Andrew Wang,Masayuki Uemura,Rosemarie Mick,Paul A. Janmey,Emma E. Furth,Rebecca G. Wells +9 more
TL;DR: Increases in liver stiffness precede fibrosis and potentially myofibroblast activation, and it is suggested that increased liver stiffness may play an important role in initiating the early stages of fibrosis.
Journal ArticleDOI
4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation
Laura Mauri,Laura Mauri,Elyse Foster,Donald D. Glower,Patricia Apruzzese,Joseph M. Massaro,Joseph M. Massaro,Howard C. Herrmann,James B. Hermiller,William A. Gray,Andrew Wang,Wesley R. Pedersen,Tanvir Bajwa,John M. Lasala,Reginald I. Low,Paul A. Grayburn,Ted Feldman,Everest Investigators +17 more
TL;DR: Patients treated with percutaneous repair of the mitral valve more commonly required surgery to treat residual MR; however, after the first year of follow-up, there were few surgeries required after either per cutaneous or surgical treatment and no difference in the prevalence of moderate-severe and severe MR or mortality at 4 years.